United States heart valve devices market is expected to witness rapid growth during the forecast period owing to rising geriatric population coupled with increasing prevalence of various heart diseases and cardiovascular disorders. The presence of well-established healthcare infrastructure and easy access to advanced healthcare services is also acting as key growth driver for United States heart valve devices market. Furthermore,
Moreover, favorable reimbursement policies and launch of advanced heart valve devices are fueling the market growth. With growing awareness about benefits of valve replacement and rise in demand for minimally invasive surgeries, the United States heart valve devices market is anticipated to undergo substantial ACGR during the forecast period. However, the risk of infection due to cardiac implants and complications related to heart valves repair and replacement surgeries are expected to hamper the market growth.
United States heart valve devices market is categorized based on
Based on end user, the United States heart valve devices market can be segmented into hospitals, ambulatory surgical centers and others. Among them, the hospital segment underwent highest growth in 2021 and is further expected to contribute to high revenue during he forecast period owing to favorable health reimbursements and increasing number of heart valve surgeries being performed.
Major players operating in the United States heart valve devices market include Abbott Laboratories, Inc., Boston Scientific Corporation, Cryolife, Inc., Edwards Lifesciences LLC, On-X Life Technologies, Inc., Micro Interventional Devices, Inc., Neovasc, Inc., Sorin Group USA, Inc., Medtronic, Inc. and St. Jude Medical, Inc., among others. The market players are focusing on new product launches and are undergoing mergers & acquisitions to increase their share in United States heart valve devices market.
Objective of the Study
- To analyze and estimate the market size of United States heart valve devices market from 2017 to 2020.
- To estimate and forecast the market size of United States heart valve devices market from 2021 to 2027 and growth rate until 2027.
- to classify and forecast United States heart valve devices market based on type, product type, valve type, procedure, application, end user, company and regional distribution.
- To identify dominant region or segment in the United States heart valve devices market.
- To identify drivers and challenges for United States heart valve devices market.
- To examine competitive developments such as expansions, mergers & acquisitions, etc., in United States heart valve devices market.
- To conduct pricing analysis for United States heart valve devices market.
- To identify and analyze the profile of leading players operating in United States heart valve devices market.
- To identify key sustainable strategies adopted by market players in United States heart valve devices market.
Click here to download the sample
Market insights research performed both primary as well as exhaustive secondary research for this study. Initially, Market insights research sourced a list of heart valve device manufacturers across United States. Subsequently, Market insights research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, Market insights research could include the manufacturers who could not be identified due to the limitations of secondary research. Market insights research analyzed the presence of all major players across the globe.
Market insights research calculated the market size of
Key Target Audience
- Heart valve devices manufacturers, suppliers, distributors and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to heart valve devices
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as heart valve device manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2021 |
| Historical Years | 2017 – 2020 |
| Estimated Year | 2022E |
| Forecast Period | 2023F – 2027F |
| Quantitative Units | Revenue in USD Million, and CAGR for 2017-2021 and 2022E-2027F |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | - Type
- Product Type
- Valve Type
- Procedure
- Application
- End User
|
| Region Scope | South-Region, West-Region, Mid-West Region & Northeast-Region |
| Key Companies Profiled | Abbott Laboratories, Inc., Boston Scientific Corporation, Cryolife, Inc., Edwards Lifesciences LLC, On-X Life Technologies, Inc., Micro Interventional Devices, Inc., Neovasc, Inc., Sorin Group USA, Inc., Medtronic, Inc. and St. Jude Medical, Inc |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
